SLC5A2 and Hypoglycemia: SGLT2 inhibitors promote glucosuria by inhibiting glucose reabsorption in the proximal renal tubule, and the associated suppression of insulin secretion and stimulation of glucagon secretion protect against hypoglycemia [14].